Institutional Ownership
Design Therapeutics Inc
CUSIP 25056L103COMDSGNQ1 2026
13D / 13G Filings
28
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
13.8%
Max % of class reported
Institutional Holders
121
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
28 filings · latest Mar 11, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 11, 2026 | Sr One Capital Fund I Aggregator, LP | 13D/A | 10.7% | — | SEC |
| 2 | Feb 17, 2026 | Point72 Asset Management, L.P. | 13G/A | 9.4% | 5.37M | SEC |
| 3 | Nov 18, 2025 | Logos Global Management LP | 13D/A | 4.4% | — | SEC |
| 4 | Nov 12, 2025 | Logos Global Management LP | 13D/A | 5.7% | — | SEC |
| 5 | Aug 28, 2025 | Point72 Asset Management, L.P. | 13G | 5.2% | 2.94M | SEC |
| 6 | Feb 7, 2025 | Star Irrevocable Trust #1 Dated April 22, 2019 | 13G/A | 6.9% | 3.83M | SEC |
| 7 | Feb 7, 2025 | Light Irrevocable Trust #1 Dated April 22, 2019 | 13G/A | 6.9% | 3.83M | SEC |
| 8 | Aug 13, 2024 | Logos Global Management LP | 13D/A | 7.4% | 4.22M | SEC |
| 9 | Feb 14, 2024 | Citadel Advisors LLC | 13G/A | 3.2% | — | SEC |
| 10 | Feb 14, 2024 | Cormorant Asset Management, LP | 13G/A | — | — | SEC |
18 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Design Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Sr One Capital Management, LP | 6.53M | $69.44M |
| 2 | Ra Capital Management, L.P. | 2.97M | $31.63M |
| 3 | Point72 Asset Management, L.P. | 2.72M | $28.97M |
| 4 | Baker Bros. Advisors LP | 2.59M | $27.51M |
| 5 | Blackrock, Inc. | 2.13M | $22.70M |
| 6 | Logos Global Management LP | 1.95M | $20.75M |
| 7 | Driehaus Capital Management LLC | 1.74M | $18.57M |
| 8 | Vivo Capital, LLC | 1.61M | $17.16M |
| 9 | Almitas Capital LLC | 1.53M | $16.28M |
| 10 | Woodline Partners LP | 961.5K | $10.23M |